Welcome to our dedicated page for Markel Corporation SEC filings (Ticker: MKL), a comprehensive resource for investors and traders seeking official regulatory documents including 10-K annual reports, 10-Q quarterly earnings, 8-K material events, and insider trading forms.
Markel Group Inc. filings document the financial reporting, governance, and capital-structure disclosures of a diversified holding company centered on specialty insurance. Its regulatory record includes 8-K reports for annual and quarterly results, Regulation FD materials such as shareholder letters, leadership and compensation changes, and reporting changes tied to business re-segmentation.
Proxy filings describe board matters, executive compensation, shareholder voting items, and equity-award disclosures. Other filings address registered securities and plan-interest matters, including Costa Farms LLC 401(k) Plan disclosures, while preserving Markel Group’s continuing reporting obligations for its common shares.
Markel Group director Greta J. Harris reported selling a total of 76 shares of Markel Group common stock in open-market transactions on May 22, 2026. The sales were executed in three small blocks at weighted average prices between about $1,846 and $1,849 per share.
MICHAEL JONATHAN E reported acquisition or exercise transactions in this Form 4 filing.
MARKEL GROUP INC. director Michael Jonathan E reported receiving a grant of 89 shares of Common Stock as restricted stock under the MKL 2024 Equity Incentive Compensation Plan. The award was made at no cash cost per share and is compensation-related rather than an open-market purchase.
The restricted shares will vest, subject to certain conditions, on May 20, 2027. Following this grant, his directly held Common Stock position reported in this filing increased to 266.8053 shares.
Morrison Harold Lawrence Jr. reported acquisition or exercise transactions in this Form 4 filing.
MARKEL GROUP INC. director Harold Lawrence Morrison Jr. received a grant of 89 shares of restricted common stock as equity compensation. The award was granted at no cash cost to him and will vest, subject to conditions, on May 20, 2027. Following this grant, he directly holds a total of 1,094.0035 common shares, reflecting a routine stock-based compensation award rather than an open-market purchase.
MARKEL GROUP INC. director Mark Besca reported receiving a grant of 89 shares of common stock as equity compensation. The shares were awarded at a price of $0.00 per share and increased his directly held position to 1,141.2525 shares after the transaction.
The award is structured as restricted stock granted under the MKL 2024 Equity Incentive Compensation Plan and will vest, subject to certain conditions, on May 20, 2027. This is a routine compensation-related acquisition rather than an open-market purchase.
Harris Greta J reported acquisition or exercise transactions in this Form 4 filing.
MARKEL GROUP INC. director Greta J. Harris received a grant of 89 shares of common stock as equity compensation at no cash cost to her. These restricted shares were issued under the MKL 2024 Equity Incentive Compensation Plan and will vest, subject to certain conditions, on May 20, 2027. Following this grant, she directly holds 721 shares of Markel Group common stock.
Cunningham Lawrence A reported acquisition or exercise transactions in this Form 4 filing.
MARKEL GROUP INC. director Lawrence A. Cunningham received an award of 89 shares of common stock on May 20, 2026. This was a restricted stock grant under the MKL 2024 Equity Incentive Compensation Plan at no cash cost to him.
The restricted shares will vest, subject to certain conditions, on May 20, 2027. After this grant, Cunningham directly holds a total of 1,008.8381 shares of Markel common stock, reflecting a routine equity-based compensation award rather than an open-market purchase.
OREILLY MICHAEL reported acquisition or exercise transactions in this Form 4 filing.
MARKEL GROUP INC. director Michael O’Reilly received a grant of 89 shares of common stock as equity compensation. The award was made at no cash cost to him and increased his direct holdings to about 3,844.7641 shares.
The footnote explains this is restricted stock granted under the MKL 2024 Equity Incentive Compensation Plan. These shares are scheduled to vest on May 20, 2027, provided specified conditions are met, which makes this a standard, long-term incentive grant rather than an open-market purchase or sale.
Housel Morgan E. reported acquisition or exercise transactions in this Form 4 filing.
MARKEL GROUP INC. director Morgan E. Housel received a grant of 89 shares of restricted common stock at no cost as equity compensation. After this award, he directly holds 963.05 shares. The restricted stock was granted under the MKL 2024 Equity Incentive Compensation Plan and will vest on May 20, 2027, subject to certain conditions.
Puckett A. Lynne reported acquisition or exercise transactions in this Form 4 filing.
Markel Group Inc. director Lynne Puckett reported an equity compensation grant of 89 shares of common stock, classified as restricted stock awarded at $0.00 per share under the MKL 2024 Equity Incentive Compensation Plan.
These restricted shares are scheduled to vest, subject to certain conditions, on May 20, 2027. Following the grant, she directly holds 441.4802 shares of Markel common stock and indirectly holds 1,463 shares through a trust where she and her spouse are co-trustees and beneficiaries.
Leopold Diane reported acquisition or exercise transactions in this Form 4 filing.
MARKEL GROUP INC. director Diane Leopold reported a compensation-related stock grant and updated holdings. She received 89 shares of Common Stock as a restricted stock award at $0.00 per share under the MKL 2024 Equity Incentive Compensation Plan, bringing her direct holdings to 2,279.0993 shares. The restricted shares will vest, subject to certain conditions, on May 20, 2027. The filing also reflects 550 shares of Common Stock held indirectly through her spouse, for which beneficial ownership is expressly disclaimed.